Ipca Laboratories Ltd

IPCALAB23 Jul 2024
Pharmaceuticals
+20.15 (+1.66%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Ipca Labs.
Ipca Laboratories Ltd
Pharmaceuticals
IPCALAB23 Jul 2024
+20.15 (+1.66%)
1D
1M
6M
1Y
5Y
All

Ipca Labs. - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
53.16%
Upper Circuit
Lower Circuit
P/E TTM
51.36
P/B Ratio
4.85
Traded Value(Cr)
0.00
EPS TTM
23.65
Book value
Dividend
0.33%

How to buy Ipca Labs. shares on nse?

To buy Ipca Labs. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Ipca Labs. share price today?

The Ipca Labs. shares price on nse is Rs.1233.95 today.

What is the market cap of Ipca Labs. shares on NSE ?

The company has a market capitalization of Rs.30794.62Cr

What is the PE & PB ratio of Ipca Labs. shares ?

PE is 51.36 and PB is 4.85

What is the 52 Week High and Low of Ipca Labs. shares?

Ipca Labs. stock price high: Rs.1374.6 Ipca Labs. stock price low: Rs.786.3

Is Ipca Labs a government-run institution?

No, IPCA Laboratories is not a government-run organization. It is a privately-owned pharmaceutical company based in India. IPCA Laboratories was founded in 1949 and has since grown to become one of the leading pharmaceutical companies in India.

Who is Ipca Labs’ owner?

IPCA Laboratories is a publicly-traded company and its ownership is spread among its shareholders. The Promoter of IPCA Labs is Mr. Premchand Godha and his family.

How well is Ipca Labs doing?

IPCA Laboratories operates in the pharmaceutical industry and has a diverse product portfolio that includes medicines for various therapeutic segments, including antimalarials, anti-bacterial, pain management, and cardiovascular drugs.

Ipca Labs’ consolidated revenue has gone from Rs. 3773.18 crores in March 2019 to  Rs. 5,829.79 crores on 31 March 2022. The net profit has gone from Rs. 443.03 crores to Rs. 910.95 crores in the same period.

Ipca Labs stock has given a positive return of 10.05% over the past three years and a negative return of -18.57% over the past one year.

 

What are the latest results of Ipca Labs?

The last fiscal result of Ipca Labs was declared in March 2022 and they reported a consolidated revenue of INR 5,829.79 crore and net profit of Rs. 910.95 crores.

What are the potential catalysts that positively impact the stock price of Ipca lab?

Some potential catalysts that may positively affect IPCA Laboratories' stock price could include:

  • Strong financial results
  • Expansion in new markets
  • Launch of new products
  • Regulatory approvals
  • Industry trends
Click here to see your activities